Lippo Village, Tangerang, Indonesia
Friday, January 12, 2018
PT Siloam International Hospitals Tbk (“Siloam”) today announces the opening of Siloam Hospitals Silampari (“SHLL”) in Lubuk Linggau city. SHLL is Siloam’s 5th hospital in the Island of Sumatra and Siloam’s 2nd hospital in the province of South Sumatra.
SHLL is a 175 bed capacity hospital located in the city of Lubuk Linggau, South Sumatra. The city is strategically located in the middle of Trans-Sumatran Highway linking 3 major cities in South Sumatra: Bengkulu (±130 km to the west), Jambi (±300 km to the north) and Palembang (±300 km to the east). The city is known for its waterfall, Temam Waterfall that has elongated shape that resembled a giant curtain similar to Niagara Falls in North America. Due to the similarity, the waterfall is called mini Niagara Falls by the locals. SHLL operates in a ±8,250 sqm five storey building on ±21,036 sqm integrated land with Lippo Plaza Lubuk Linggau. The hospital is equipped with state-of-the-art medical equipment such as 64- slice CT-Scan, the one and only in the city, and supported by 20 specialists and 8 general practitioners as well as 51 nurses. In the future, the hospital will be registered to serve BPJS Kesehatan patients.
Ketut Budi Wijaya, President Director of Siloam stated, "After a month delay, we are pleased to announce the opening of SHLL, our first hospital opening in 2018. SHLL will provide high quality patient care and services for 216 thousand people living in Lubuk Linggau city as well as over 3 million people living in the surrounding regencies. With the only 64-slice CT-Scan in city, we are providing the finest imaging tool that will allow the doctors to analyse patients more accurately. Making modern healthcare affordable and accessible to the community has been the driving force of our expansion plan and we believe the opening of SHLL will bring positive impact to the community.”
Siloam is a subsidiary of PT Lippo Karawaci Tbk (“LPKR”), the largest listed property company in Indonesia by total assets and revenues, anchored by a large land bank and solid recurring income base. LPKR's businesses comprise Residential/Township, Retail Malls, Hospitals, Hotels and Asset Management.
Siloam now operates 32 hospitals in 23 cities throughout the country receiving more than 2 million visits & admissions and carrying out more than 41,000 surgeries every year. The 6,300 beds capacities are supported by about 2,700 specialists and general practitioners as well as over 9,600 nurses and support staff. It also manages the first JCI accredited hospital in Indonesia and a repeat winner of “Frost & Sullivan, Indonesia’s Healthcare Service Provider of the Year”. Siloam is listed on the Indonesian Stock Exchange under the ticker name “SILO” and a market capitalization of Rp 14.3 trillion or USD 1,066.7 million as of January 11, 2018.
For more information, please contact:
Anastasia Trivena Haliem
Investor Relations Manager
Siloam Hospitals Group
This press release has been prepared by PT Siloam International Hospitals Tbk (“Siloam”) and is circulated for the purpose of general information only. It is not intended for any specific person or purpose and does not constitute a recommendation regarding the securities of Siloam. No warranty (expressed or implied) is made to the accuracy or completeness of the information. All opinions and estimations included in this release constitute our judgment as of this date and are subject to change without prior notice. Siloam disclaims any responsibility or liability whatsoever arising which may be brought against or suffered by any person as a result of reliance upon the whole or any part of the contents of this press release and neither Siloam nor any of its affiliated companies and their respective employees and agents accepts liability for any errors, omissions, negligent or 3 otherwise, in this press release and any inaccuracy herein or omission here from which might otherwise arise.
Forward-Looking Statements. Certain statements in this release are or may be forward- looking statements. These statements typically contain words such as "will", "expects" and "anticipates" and words of similar import. By their nature, forward looking statements involve a number of risks and uncertainties that could cause actual events or results to differ materially from those described in this release. Factors that could cause actual results to differ include, but are not limited to, economic, social and political conditions in Indonesia; the state of the healthcare industry in Indonesia; prevailing market conditions; increases in regulatory burdens in Indonesia, including environmental regulations and compliance costs; fluctuations in foreign currency exchange rates; interest rate trends, cost of capital and capital availability; the anticipated demand and selling prices for our healthcare and related capital expenditures and investments; the cost of construction; availability of healthcare; competition from other companies and venues; shifts in customer demands; changes in operation expenses, including employee wages, benefits and training, governmental and public policy changes; our ability to be and remain competitive; our financial condition, business strategy as well as the plans and objectives of our management for future operations; generation of future receivables; and environmental compliance and remediation. Should one or more of these uncertainties or risks, among others, materialize, actual results may vary materially from those estimated, anticipated or projected. Specifically, but without limitation, capital costs could increase, projects could be delayed and anticipated improvements in production, capacity or performance might not be fully realized. Although we believe that the expectations of our management as reflected by such forward-looking statements are reasonable based on information currently available to us, no assurances can be given that such expectations will prove to have been correct. You should not unduly rely on such statements. In any event, these statements speak only as of the date hereof, and we undertake no obligation to update or revise any of them, whether as a result of new information, future events or otherwise.